Receive our newsletter – data, insights and analysis delivered to you
  1. News
September 10, 2017updated 14 Nov 2021 1:28pm

NuVasive buys interbody implants firm Vertera Spine

US-based medical device firm NuVasive has acquired interbody implants provider Vertera Spine, expanding its advanced materials science portfolio.

US-based medical device firm NuVasive has acquired interbody implants provider Vertera Spine, expanding its advanced materials science portfolio.

Financial details of the deal have not been disclosed.

Vertera uses patented porous polyetheretherketone (PEEK) technology to develop and commercialise implants for spinal fusion.

Using a specific processing method to retain strength and durability, the technology offers a three-dimensional porous PEEK architecture that is said to aid the stimulation of bone ingrowth in patients who have undergone spinal fusion procedures.

The acquisition will now allow NuVasive to deliver porous interbody technology across PEEK and titanium materials to serve different needs and preferences of surgeons for interbody implants.

“This helps to create more predictable, improved outcomes for patients undergoing spine surgery.”

NuVasive chairman and CEO Gregory Lucier said: “With the addition of porous PEEK technology, NuVasive takes the next step in building out its advanced materials science technology focused on delivering the highest level of scientifically driven properties for best spinal fusion rates, including porosity, visualisation, surface, and structure.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

“This, in turn, helps to create more predictable, improved outcomes for patients undergoing spine surgery.”

The firm plans to add Vertera’s products to its commercial offerings and further use the porous PEEK technology during development of new products.

Vertera’s current interbody product portfolio includes the US Food and Drug Administration (FDA) cleared COHERE cervical interbody fusion device and COALESCE device that is designed for anterior, transforaminal, posterior and lateral lumbar interbody fusion procedures.

The firm is planning to secure extensions of COALESCE for posterior and transforaminal lumbar interbody fusion.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU